[When statins alone are insufficient for lowering lipid levels. Efficacy and risks of lipid lowering combination therapies, in particular, that of statin-fibrate combination].
Otto
C
C
Medizinische Klinik II, Klinikum Grosshadern, Ludwig-Maximilians-Universität München.
Schwandt
P
P
D003327:Coronary Disease / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use*; D012855:Sitosterols / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D012855:Sitosterols; D009525:Niacin; C025473:gamma-sitosterol